Clinical trial
Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic…
NCT00460629 · University Hospital Carl Gustav Carus, Other · Completed
Key facts
| NCT number | NCT00460629 |
|---|---|
| Title | Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation |
| Official title | Specific Cellular Immunotherapy in Patients With Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation |
| Lead sponsor | University Hospital Carl Gustav Carus, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Myeloid Leukemia |
| Intervention type | Procedure |
| Interventions | Application of activated donor T cells |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2011 |
| First posted | Apr 16, 2007 |
| Last update posted | Jun 20, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: